Aligos Therapeutics (ALGS) delivered earnings and revenue surprises of -78.53% and 51.62%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock ...

Aligos Therapeutics, Inc. (ALGS) came out with a quarterly loss ... Aligos Therapeutics, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.63 million ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Aligos Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses ...

Brain cells, or oligodendrocytes (green), in the hippocampus are marked with a genetic marker in the mouse brain in the study. These cells often deteriorate during aging. Gadek et al., Science ...

Genetic engineering is the act of modifying the genetic makeup of an organism. Modifications can be generated by methods such as gene targeting, nuclear transplantation, transfection of synthetic ...

Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for ...

Gregor Mendel's principles of inheritance form the cornerstone of modern genetics. So just what are they? When looking at the figure, notice that for each F 1 plant, the self-fertilization ...